Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1999
11/02/1999US5977158 Pharmaceutical formulations comprising levormeloxifene compounds
11/02/1999US5977157 Methods for inhibiting endometriosis
11/02/1999US5977155 Cardiovascular, kidneys
11/02/1999US5977154 Obesity, diabetes
11/02/1999US5977152 Triazole antifungal agent
11/02/1999US5977151 Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics
11/02/1999US5977150 Amino acid derivatives of diaryl 1,3,4-oxadiazolone
11/02/1999US5977147 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino- 1,3-propanediols and related compounds
11/02/1999US5977145 Method of treating migraine
11/02/1999US5977144 Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
11/02/1999US5977143 Medicament against infertility which reduces phagocytosis of spermatozoa in women
11/02/1999US5977142 Oxa-and thia-diazole muscarinic receptor antagonists
11/02/1999US5977140 N-[(4-Heteroaryl-1-Piperidinyl)Alkly] Phthalimides and related compounds and their therapeutic utility
11/02/1999US5977136 Tetrahydroquinolines as NMDA antagonists
11/02/1999US5977135 Bicyclic heterocycles
11/02/1999US5977132 Prolactin production inhibitory agent
11/02/1999US5977131 Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents
11/02/1999US5977130 Intimal hypertrophy inhibitors
11/02/1999US5977129 Alzheimer's disease
11/02/1999US5977128 Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
11/02/1999US5977127 Water soluble stabilizing acid additive whose pks value falls within a given range, such as citric acid or absorbic acid in specific molar ratio
11/02/1999US5977126 Antiangrogens, enzyme inhbitors
11/02/1999US5977124 β-adrenergic agonists
11/02/1999US5977122 Antiinflammatory, antiallergens, tumor necorsis factor inhibitor
11/02/1999US5977121 Use of moxonidine for the treatment of atherosclerosis
11/02/1999US5977120 Composition for achieving an alert, yet calm state
11/02/1999US5977119 Trisubstituted thioxanthines
11/02/1999US5977118 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones and compositions and methods of use thereof
11/02/1999US5977117 Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
11/02/1999US5977115 Alpha 1a adrenergic receptor antagonists
11/02/1999US5977113 4-heteroaryl-1-piperazine alkylamines and their therapeutic utility
11/02/1999US5977112 Process of making substituted benzofurans
11/02/1999US5977111 Thiopyran derivatives
11/02/1999US5977109 Sacchrides, storage stability, antitumor
11/02/1999US5977108 Leukemia
11/02/1999US5977107 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists
11/02/1999US5977106 3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives
11/02/1999US5977105 Compounds
11/02/1999US5977104 Use of NK-1 receptor antagonists for treating bipolar disorders
11/02/1999US5977103 Substituted imidazole compounds
11/02/1999US5977102 Inhibitory effect on signal transduction mediated by tyrosine kinases or epidermal growth factor; antitumor,-carcinogenic, -metastasis,-proliferation agents and -inflammatory agents; psoriasis; angiogenesis inhibitors; immunology;
11/02/1999US5977099 Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
11/02/1999US5977098 Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods
11/02/1999US5977097 1-methylcarbapenem derivatives
11/02/1999US5977096 Steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances
11/02/1999US5977095 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and respiratory distress syndrome
11/02/1999US5977094 Methods and compositions using Δ16 unsaturated C17 heterocyclic steroids useful as steroid C17-20 lyase inhibitors
11/02/1999US5977093 Inhibiting estrogen-dependent cancer
11/02/1999US5977092 Drug for curing/ameliorating concomitant syndrome of tumor
11/02/1999US5977091 Tetracycline adminsteration
11/02/1999US5977090 Pharmaceutical compositions and methods of treating compulsive disorders using NAALADase inhibitors
11/02/1999US5977088 Formulations containing hyaluronic acid
11/02/1999US5977087 Topical preparation for treatment of aphthous ulcers and other lesions
11/02/1999US5977086 Method of inhibiting human immunodeficiency virus by combined use of hydroxyurea, a nucleoside analog, and a protease inhibitor
11/02/1999US5977085 Vectors carrying coding sequence for the SpsB protein of Staphylococcus aureus
11/02/1999US5977084 Self-assembling polynucleotide delivery method
11/02/1999US5977082 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
11/02/1999US5977081 Triterpene saponin analogs having adjuvant and immunostimulatory activity
11/02/1999US5977079 Injecting a carbohydrate antigen
11/02/1999US5977077 Xanthone analogs for the treatment of infectious diseases
11/02/1999US5977070 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
11/02/1999US5977069 Mixture of growth hormone and asparagine as stabilizer
11/02/1999US5977061 Viricide against dna viruses
11/02/1999US5976884 Methods for quantifying photoreactions in light activated materials
11/02/1999US5976879 Antisense oligonucleotides which combat aberrant splicing and methods of using the same
11/02/1999US5976849 Human E3 ubiquitin protein ligase
11/02/1999US5976814 DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
11/02/1999US5976781 Diagnosing malaria by mixing blood with enzyme inhibitor, determining enzyme activity, comparing to control sample; plasmodium enzyme is more sensitive to inhibition so deactivation indicates disease
11/02/1999US5976616 Polyurethane foam materials with skin conditioning additives
11/02/1999US5976597 Basic protein composition, basic peptide composition and application thereof
11/02/1999US5976578 Mixture of antacid, preservative, buffer in aqueous vehicle
11/02/1999US5976577 Process for preparing fast dispersing solid oral dosage form
11/02/1999US5976576 Active material is n-4-(1h-tetrazol-5-yl)phenyl-4-(1h-tetrazol-5-yl)benzamide, disodium salt
11/02/1999US5976574 Forming a suspension; spray drying
11/02/1999US5976573 Aqueous-based pharmaceutical composition
11/02/1999US5976570 Aqueous solution containing surfactants; granulation
11/02/1999US5976566 Non-steroidal antiinflammtory drug formulations for topical application to the skin
11/02/1999US5976565 Device for topical treatment of acne and its method of manufacture
11/02/1999US5976560 Products suitable for application to the skin. it is comprised ofvegetable oil and silica.
11/02/1999US5976559 Compositions and methods for treating wrinkles and/or fine lines of the skin
11/02/1999US5976558 Silicone-containing derivatives of salicylic acid which have desquamating properties
11/02/1999US5976556 Combination of acid protease enzymes and acidic buffers and uses thereof
11/02/1999US5976546 Antigen presenting cells activated by contact with a polypeptide complex constructed by joining together a dendritic cell-binding protein and a polypeptide antigen.
11/02/1999US5976534 Inhibition of intimal hyperplasia using antibodies to PDGF receptors and heparin
11/02/1999US5976523 Method for healing compromised tissues using pyrimidine derivatives
11/02/1999US5976521 Anti-acne cosmetic compositions
11/02/1999US5976517 Hair care composition including at least one silicone polymer grafted by anionic, amphoteric or non-ionic monomers, and at least one amphoteric polymer
11/02/1999US5976514 Including a volatile, nonpolar hydrocarbon liquid having a solubility parameter of less than about 7.5 (cal/cm.3)0.5 and a vapor pressure as measured at 25 degrees c. of from 0.01 mmhg to about 6.0 mmhg.
11/02/1999US5976513 UV protection compositions
11/02/1999US5976504 Topical aerosol formulation for cooling of mammalian tissues
11/02/1999CA2185424C Process for making solid dose forms containing bismuth
11/02/1999CA2161542C Novel 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives
11/02/1999CA2160689C New method of treatment
11/02/1999CA2119443C Human cyclin e
11/02/1999CA2106295C Control of sea lice in seawater fish
11/02/1999CA2079486C Chelator compositions comprising alpha- diamine compounds
11/02/1999CA2077621C Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
11/02/1999CA2023311C Furan derivatives
10/1999
10/30/1999CA2270754A1 Selection process for bacterial strain
10/28/1999WO1999054707A2 Fetal testing for prediction of low birth weight
1 ... 6420 6421 6422 6423 6424 6425 6426 6427 6428 6429 6430 6431 6432 6433 6434 6435 6436 6437 6438 6439 6440 ... 7860